Compositions and methods for the identification of agents useful for the treatment of neurological disorders, including schizophrenia, are provided.
SCHIZOPHRENIA-ASSOCIATED GENETIC LOCI IDENTIFIED IN GENOME WIDE ASSOCIATION STUDIES AND USE THEREOF AS NOVEL THERAPEUTIC TARGETS